Buckley P F
Department of Psychiatry, Case Western Reserve University, and Northcoast Behavioral Healthcare System, Cleveland, Ohio 44106, USA.
J Clin Psychiatry. 1999;60 Suppl 10:52-60.
The management of agitation and aggression in psychiatric inpatients is a significant clinical dilemma. Establishing a clear diagnosis and distinguishing whether aggression is an acute manifestation or a long-standing or repetitive problem are fundamental antecedents of medication treatment. For acute aggression, either benzodiazepines or antipsychotic medications (typical and atypical) are recommended choices. Currently, on the basis of efficacy, ease of use, and availability in multiple (tablet, liquid, intramuscular) preparations, typical antipsychotics such as loxapine should be considered as first choice for acute aggression (in psychosis). On the other hand, atypical antipsychotics, particularly clozapine, should be considered when aggression in psychosis persists and/or is repetitive. Typical antipsychotics are indicated for persistent aggression in psychosis when medication noncompliance is the obstacle to effective treatment.
精神科住院患者激越与攻击行为的管理是一个重大的临床难题。明确诊断并区分攻击行为是急性表现还是长期存在或反复出现的问题,是药物治疗的基本前提。对于急性攻击行为,推荐使用苯二氮䓬类药物或抗精神病药物(传统型和非典型)。目前,基于疗效、易用性以及多种剂型(片剂、液剂、注射剂)的可获得性,对于急性攻击行为(伴精神病性症状),洛沙平之类的传统抗精神病药物应被视为首选。另一方面,当伴精神病性症状的攻击行为持续存在和/或反复出现时,应考虑使用非典型抗精神病药物,尤其是氯氮平。当药物依从性成为有效治疗的障碍时,传统抗精神病药物适用于伴精神病性症状的持续性攻击行为。